search
leukemia
Trends
- 1
Researchers reporting through the American Association for Cancer Research say genomic studies are uncovering new layers of the biology behind leukemia in children. The work points to finer genetic characterisation of pediatric cancers, which could shape how young patients are diagnosed, risk-stratified and treated. Details of the findings, study size and clinical implications have not been made clear in the available information.
- 2NIH grants $11.7 million for blood cancer inflammation research▼$11.7 million from NIH supports research on inflammation in blood cancers
The National Institutes of Health has awarded $11.7 million to WashU Medicine to fund research into the role of inflammation in blood cancers. The grant will support scientists studying how inflammatory processes drive the development and progression of cancers such as leukemia and lymphoma, with the goal of identifying new treatment targets for patients.
- 3Teen's Red Hand Patches During Leukemia Treatment Traced to Controller Grip▼A Teen Gamer's Red Hand Patches Looked Worrying During Leukemia Treatment, Until Doctors Checked His Controller Grip
A teenage boy undergoing leukemia treatment developed red patches on his hands, raising concern among his doctors. The mystery was solved when it emerged the marks were caused by his gaming controller grip, not his illness or medication. The case highlights how everyday habits can mimic treatment side effects, and doctors are using it to remind families to share details of daily routines during cancer care.
- 4Wayne State PhD student wins NIH grant for Down syndrome leukemia research▼Wayne State doctoral student receives NIH support for research into childhood leukemia associated with Down syndrome
A Wayne State University doctoral student has received support from the National Institutes of Health to fund research into childhood leukemia associated with Down syndrome. Children with Down syndrome face a significantly higher risk of developing leukemia, and the NIH funding will help advance studies aimed at understanding and potentially treating the disease. The award highlights Wayne State's growing biomedical research profile.
- 5Moleculin Closes Enrollment in MIRACLE Acute Myeloid Leukemia Trial●Enrollment Closed: What Moleculin’s MIRACLE Trial Teaches About AML Site Execution
Moleculin Biotech has closed enrollment in its MIRACLE trial for acute myeloid leukemia, a step that shifts attention from recruiting patients to follow-up and data collection. Commentary around the milestone is focusing on what the trial's execution across clinical sites reveals about running complex AML studies. Observers in the oncology and biotech community are watching for next results.
- 6Leukemia Survivor Opens Up About Lasting Physical and Mental Toll▼Beyond the Diagnosis: Leukemia's Physical and Mental Toll on a Young Adult Survivor
A young adult leukemia survivor has shared an account of the disease's long-term impact that goes beyond the diagnosis itself, describing lasting physical effects and the mental health strain of treatment and recovery. The story highlights the often-overlooked after-effects faced by young cancer patients once active treatment ends.